{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:34:06Z","timestamp":1789842846747,"version":"4.0.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,1]]},"DOI":"10.7759\/cureus.76710","type":"journal-article","created":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T08:14:42Z","timestamp":1735719282000},"source":"Crossref","is-referenced-by-count":1,"title":["A Case of Essential Thrombocythemia Treated for Epileptic Peri-Ictal Psychiatric Symptoms Resulting in Appropriate Palliative Care"],"prefix":"10.7759","author":[{"given":"Tetsuro","family":"Ishida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber DA","year":"2022","unstructured":"Arber DA, Orazi A, Hasserjian RP, et al.. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022, 140:1220-8. 10.1182\/blood.2022015850","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.255117","article-title":"Acquired von Willebrand syndrome: focused for hematologists","volume":"105","author":"Franchini M","year":"2020","unstructured":"Franchini M, Mannucci PM. Acquired von Willebrand syndrome: focused for hematologists. Haematologica. 2020, 105:2032-7. 10.3324\/haematol.2020.255117","journal-title":"Haematologica"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0074-7742(06)81008-1","article-title":"Diagnosing of epilepsy in the elderly","volume":"81","author":"Ramsay RE","year":"2007","unstructured":"Ramsay RE, Macias FM, Rowan AJ. Diagnosing of epilepsy in the elderly. Int Rev Neurobiol. 2007, 81:129-51. 10.1016\/S0074-7742(06)81008-1","journal-title":"Int Rev Neurobiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2019.1636649","article-title":"Timing use of novel anti-epileptic drugs: is earlier better?","volume":"19","author":"de Biase S","year":"2019","unstructured":"de Biase S, Nilo A, Bernardini A, Gigli GL, Valente M, Merlino G. Timing use of novel anti-epileptic drugs: is earlier better?. Expert Rev Neurother. 2019, 19:945-54. 10.1080\/14737175.2019.1636649","journal-title":"Expert Rev Neurother"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2020.1843636","article-title":"New anti-seizure medication for elderly epilepsy patients - a critical narrative review","volume":"22","author":"Rohracher A","year":"2021","unstructured":"Rohracher A, Kalss G, Kuchukhidze G, et al.. New anti-seizure medication for elderly epilepsy patients - a critical narrative review. Expert Opin Pharmacother. 2021, 22:621-34. 10.1080\/14656566.2020.1843636","journal-title":"Expert Opin Pharmacother"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.01021.x","article-title":"No treatment for low-risk thrombocythaemia: results from a prospective study","volume":"103","author":"Ruggeri M","year":"1998","unstructured":"Ruggeri M, Finazzi G, Tosetto A, Riva S, Rodeghiero F, Barbui T. No treatment for low-risk thrombocythaemia: results from a prospective study. Br J Haematol. 1998, 103:772-7. 10.1046\/j.1365-2141.1998.01021.x","journal-title":"Br J Haematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4065\/81.2.159","article-title":"Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors","volume":"81","author":"Wolanskyj AP","year":"2006","unstructured":"Wolanskyj AP, Schwager SM, McClure RF, Larson DR, Tefferi A. Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors. Mayo Clin Proc. 2006, 81:159-66. 10.4065\/81.2.159","journal-title":"Mayo Clin Proc"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-01-403279","article-title":"A prognostic model to predict survival in 867 World Health Organization-defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment","volume":"120","author":"Passamonti F","year":"2012","unstructured":"Passamonti F, Thiele J, Girodon F, et al.. A prognostic model to predict survival in 867 World Health Organization-defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment. Blood. 2012, 120:1197-201. 10.1182\/blood-2012-01-403279","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.94","article-title":"Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia","volume":"5","author":"Barbui T","year":"2015","unstructured":"Barbui T, Vannucchi AM, Buxhofer-Ausch V, et al.. Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia. Blood Cancer J. 2015, 5:e369. 10.1038\/bcj.2015.94","journal-title":"Blood Cancer J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21360","article-title":"Long-term follow-up of 386 consecutive patients with essential thrombocythemia: safety of cytoreductive therapy","volume":"84","author":"Palandri F","year":"2009","unstructured":"Palandri F, Catani L, Testoni N, et al.. Long-term follow-up of 386 consecutive patients with essential thrombocythemia: safety of cytoreductive therapy. Am J Hematol. 2009, 84:215-20. 10.1002\/ajh.21360","journal-title":"Am J Hematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043800","article-title":"Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia","volume":"353","author":"Harrison CN","year":"2005","unstructured":"Harrison CN, Campbell PJ, Buck G, et al.. Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia. N Engl J Med. 2005, 353:33-45. 10.1056\/NEJMoa043800","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1006\/ebeh.2000.0113","article-title":"Proposal for a new five-axis classification scheme for psychoses of epilepsy","volume":"1","author":"Matsuura M","year":"2000","unstructured":"Matsuura M, Adachi N, Oana Y, Okubo Y, Hara T, Onuma T. Proposal for a new five-axis classification scheme for psychoses of epilepsy. Epilepsy Behav. 2000, 1:343-52. 10.1006\/ebeh.2000.0113","journal-title":"Epilepsy Behav"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-07-443770","article-title":"Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial","volume":"121","author":"Gisslinger H","year":"2013","unstructured":"Gisslinger H, Gotic M, Holowiecki J, et al.. Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial. Blood. 2013, 121:1720-8. 10.1182\/blood-2012-07-443770","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2012.06.015","article-title":"Nonconvulsive status epilepticus in elderly a possible diagnostic pitfall","volume":"23","author":"Shavit L","year":"2012","unstructured":"Shavit L, Grenader T, Galperin I. Nonconvulsive status epilepticus in elderly a possible diagnostic pitfall. Eur J Intern Med. 2012, 23:701-4. 10.1016\/j.ejim.2012.06.015","journal-title":"Eur J Intern Med"},{"key":"ref15","unstructured":"Clinical practice guidelines for epilepsy. (2018). Accessed. 2024\/06\/27: https:\/\/www.neurology-jp.org\/guidelinem\/epilepsy\/documents\/guideline2018.pdf."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher RS","year":"2014","unstructured":"Fisher RS, Acevedo C, Arzimanoglou A, et al.. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014, 55:475-82. 10.1111\/epi.12550","journal-title":"Epilepsia"},{"key":"ref17","article-title":"Psychiatric comorbidity in epilepsy [Article in Japanese]","volume":"23","author":"Yamada N","year":"2011","unstructured":"Yamada N. Psychiatric comorbidity in epilepsy [Article in Japanese]. Japan J Gen Hosp Psychiatry. 2011, 23:27-34.","journal-title":"Japan J Gen Hosp Psychiatry"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13670","article-title":"Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Fisher RS","year":"2017","unstructured":"Fisher RS, Cross JH, French JA, et al.. Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017, 58:522-30. 10.1111\/epi.13670","journal-title":"Epilepsia"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199802123380704","article-title":"Risk of recurrent seizures after two unprovoked seizures","volume":"338","author":"Hauser WA","year":"1998","unstructured":"Hauser WA, Rich SS, Lee JR, Annegers JF, Anderson VE. Risk of recurrent seizures after two unprovoked seizures. N Engl J Med. 1998, 338:429-34. 10.1056\/NEJM199802123380704","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.40.8.1163","article-title":"Seizure recurrence after a 1st unprovoked seizure: an extended follow-up","volume":"40","author":"Hauser WA","year":"1990","unstructured":"Hauser WA, Rich SS, Annegers JF, Anderson VE. Seizure recurrence after a 1st unprovoked seizure: an extended follow-up. Neurology. 1990, 40:1163-70. 10.1212\/wnl.40.8.1163","journal-title":"Neurology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/271940-a-case-of-essential-thrombocythemia-treated-for-epileptic-peri-ictal-psychiatric-symptoms-resulting-in-appropriate-palliative-care","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T08:14:44Z","timestamp":1735719284000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/271940-a-case-of-essential-thrombocythemia-treated-for-epileptic-peri-ictal-psychiatric-symptoms-resulting-in-appropriate-palliative-care"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.76710","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,1]]}}}